2026-01-30 Decoding the ERS–CAF immunoregulatory axis via multimodal AI and its pan-cancer prognostic and therapeutic predictive value
2026-01-28 Molecular profiling of primary versus paired asynchronous metastatic clear cell renal cell carcinoma reveals heterogeneity in tumor immune microenvironment
2026-01-28 Multimodal single-cell profiling reveals crosstalk between macrophages and stromal cells in poor prognostic cholangiocarcinoma patients
2026-01-26 A proteogenomic atlas of 1032 brain metastases identifies molecular subtypes, immune landscapes, and therapeutic vulnerabilities
2026-01-26 Priming versus propagating: distinct immune effects of alpha- versus beta-particle emitting radiopharmaceuticals when combined with immune checkpoint inhibition in mice
2026-01-26 Co-delivery of chemokine CXCL9 and costimulatory ligand TNFSF9 by mesenchymal stem cells reprograms the immune microenvironment for triple-negative breast cancer
2026-01-24 Research on the molecular mechanism of celastrol targeting CTNNB1/STAT3 to inhibit uveal melanoma based on network pharmacology and multi-omics analysis
2026-01-24 Identification and characterization of MARCO-expressing tumor-associated macrophages in pancreatic ductal adenocarcinoma with pan-cancer relevance
2026-01-23 An integrated single-cell lung cancer atlas reveals distinct fibroblast phenotypes between adenocarcinoma and squamous cell carcinomas
2026-01-22 A deep learning radiopathomic signature predicts recurrence risk of hepatocellular carcinoma after hepatectomy
2026-01-21 In situ self-assembled cell reservoir hydrogel for maneuvering multistage radioimmunotherapy
2026-01-21 Application of group A streptococcal collagen-like protein 1-expressing Lactococcus as a novel immunotherapeutic against pancreatic ductal adenocarcinoma
2026-01-21 Towards the tumor microenvironment scoring methods for immune checkpoint inhibitor response
2026-01-21 Preoperative positive ctDNA analysis is associated with the tumor microenvironment, and the risk of recurrence in non-metastatic colorectal cancer
2026-01-20 Identification and verification of SPP1 in anoikis as a prognostic biomarker for intestinal metaplasia and gastric cancer
2026-01-20 Evaluation of immuno-oncologic biomarkers and β-catenin expression in response of hepatocellular carcinomas to immunotherapy
2026-01-19 In vitro experiments and bioinformatic analyses implicate KAT2A in the occurrence and development of hepatocellular carcinoma
2026-01-19 Identification of TMEM59L as a potential diagnosis, prognosis and immunotherapy biomarker for colon adenocarcinoma
2026-01-18 The tumor microenvironment in esophageal cancer and its association with clinical features and neoadjuvant treatment response
2026-01-17 Host-derived interleukin-1α drives tumor immunosuppression by reprogramming tumor-associated myeloid cells
2026-01-17 Neoadjuvant sintilimab, albumin-bound paclitaxel, and carboplatin for locally advanced, resectable esophageal squamous cell carcinoma: clinical study and mechanistic exploration
2026-01-16 Robust and interpretable prediction of gene markers and cell types from spatial transcriptomics data
2026-01-16 Multiscale imaging on proton pump-driven acidity for assessing tumor progression and metastasis
2026-01-16 Spatiotemporally controlled drug release via a click-release system utilizing mono-alkyl-hydroxylamine and cyclooctyne chemistry
2026-01-14 Rab37-mediated OPN secretion enriches SPP1+ macrophages through autocrine–paracrine signaling to drive lung tumor progression
2026-01-14 Interaction between ELMO1 DNA methylation and Med31 promotes H. pylori-induced gastric cancer EMT and intestinal metaplasia via M2 polarization
2026-01-13 Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial
2026-01-08 Deubiquitination-related genes define immune subtypes of colorectal cancer and are associated with prognosis and immunotherapy-related signatures